Cargando…

Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications – a review

Peroxisome proliferator-activated receptors are expressed in many tissues, including adipocytes, hepatocytes, muscles and endothelial cells; however, the affinity depends on the isoform of PPAR, and different distribution and expression profiles, which ultimately lead to different clinical outcomes....

Descripción completa

Detalles Bibliográficos
Autor principal:	Grygiel-Górniak, Bogna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943808/ https://www.ncbi.nlm.nih.gov/pubmed/24524207 http://dx.doi.org/10.1186/1475-2891-13-17

Ejemplares similares

Molecular Background and Clinical Implications of Glucose Disorders in Patients with Psoriatic Arthritis
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2023)

Antinuclear antibodies in healthy people and non-rheumatic diseases – diagnostic and clinical implications
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2018)

Clinical implications of systemic lupus erythematosus without and with antiphospholipid syndrome in peri- and postmenopausal age
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2018)

Antimalarial drugs—are they beneficial in rheumatic and viral diseases?—considerations in COVID-19 pandemic
por: Grygiel-Górniak, Bogna
Publicado: (2021)

Fatigue and interleukin-6 – a multi-faceted relationship
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2015)

Oxidative Damage and Antioxidative Therapy in Systemic Sclerosis
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2014)

COVID-19: What Should the General Practitioner Know?
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2021)

Chlamydia trachomatis—An Emerging Old Entity?
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2023)

The influence of endogenous and exogenous sex hormones on systemic lupus erythematosus in pre- and postmenopausal women
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2014)

The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development
por: Hong, Fan, et al.
Publicado: (2018)

Physical activity, nutritional status, and dietary habits of students of a medical university
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2016)

Comparative Evaluation of Gemcabene and Peroxisome Proliferator–Activated Receptor Ligands in Transcriptional Assays of Peroxisome Proliferator–Activated Receptors: Implication for the Treatment of Hyperlipidemia and Cardiovascular Disease
por: Bisgaier, Charles L., et al.
Publicado: (2018)

Oxidative Stress in Fibromyalgia: From Pathology to Treatment
por: Assavarittirong, Chanika, et al.
Publicado: (2022)

Positive antiphospholipid antibodies: observation or treatment?
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2023)

Placental Implications of Peroxisome Proliferator-Activated Receptors in Gestation and Parturition
por: Borel, Valerie, et al.
Publicado: (2008)

SARS-CoV-2 infection in the context of Kawasaki disease and multisystem inflammatory syndrome in children
por: Folga, Barbara Anna, et al.
Publicado: (2022)

Impact of Dietary Protein on Osteoporosis Development
por: Kędzia, Gabriela, et al.
Publicado: (2023)

Activation and Molecular Targets of Peroxisome Proliferator-Activated Receptor-γ Ligands in Lung Cancer
por: Nemenoff, Raphael A., et al.
Publicado: (2008)

Antinuclear antibodies in autoimmune and allergic diseases
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2017)

Implications of a peroxisome proliferator-activated receptor alpha (PPARα) ligand clofibrate in breast cancer
por: Chandran, Karthic, et al.
Publicado: (2015)

Role of Peroxisome Proliferator-Activated Receptor Gamma and Its Ligands in the Treatment of Hematological Malignancies
por: Garcia-Bates, Tatiana M., et al.
Publicado: (2008)

The Potential Applications of Peroxisome Proliferator-Activated Receptor δ Ligands in Assisted Reproductive Technology
por: Huang, Jaou-Chen
Publicado: (2008)

Assessment of total, ligand-induced peroxisome proliferator activated receptor γ ligand activity in serum
por: Edwards, Lariah, et al.
Publicado: (2019)

Chondrosarcoma and Peroxisome Proliferator-Activated Receptor
por: Nishida, K., et al.
Publicado: (2008)

Astaxanthin as a Peroxisome Proliferator-Activated Receptor (PPAR) Modulator: Its Therapeutic Implications
por: Choi, Chang-Ik
Publicado: (2019)

Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer
por: Wagner, Nicole, et al.
Publicado: (2022)

The Role of Peroxisome Proliferator-Activated Receptors in Preeclampsia
por: Psilopatis, Iason, et al.
Publicado: (2023)

Osteoarthritis: Role of Peroxisome Proliferator-Activated Receptors
por: Sheng, Weibei, et al.
Publicado: (2023)

Peroxisome Proliferator Activated Receptor Ligands as Regulators of Airway Inflammation and Remodelling in Chronic Lung Disease
por: Ward, Jane Elizabeth, et al.
Publicado: (2007)

Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease
por: Fougerat, Anne, et al.
Publicado: (2020)

CHARMM Force Field Parameterization of Peroxisome Proliferator-Activated Receptor γ Ligands
por: Mottin, Melina, et al.
Publicado: (2016)

Ligands of the peroxisome proliferator-activated receptor γ inhibit hepatoce llular carcinoma cell proliferation
por: Jin, Zhe, et al.
Publicado: (2017)

Peroxisome Proliferator-Activated Receptors in Lung Cancer
por: Keshamouni, Venkateshwar G., et al.
Publicado: (2007)

Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism
por: Kersten, Sander
Publicado: (2008)

Peroxisome Proliferator-Activated Receptors in Diabetic Nephropathy
por: Kume, Shinji, et al.
Publicado: (2008)

Peroxisome Proliferator-Activated Receptors and Shock State
por: Esposito, Emanuela, et al.
Publicado: (2006)

Selective peroxisome proliferator-activated receptorα modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
por: Fruchart, Jean-Charles
Publicado: (2013)

Chemerin, Resistin, and Adiponectin in Patients with Connective Tissue Diseases
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2018)

The Role of Peroxisome Proliferator-Activated Receptors in Endometrial Cancer
por: Psilopatis, Iason, et al.
Publicado: (2023)

Ligand-Regulated Heterodimerization of Peroxisome Proliferator-Activated Receptor α with Liver X Receptor α
por: Balanarasimha, Madhumitha, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_g023d1oihnohtnal32im3mouf9